Exelixis
EXEL
#1769
Rank
S$15.23 B
Marketcap
S$56.60
Share price
0.05%
Change (1 day)
16.93%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no dividend yield history for this company